Articles

Pfizer’s stock gains after the drugmaker boosted its full-year profit outlook.

The stand-up comedian has had a busy year, with a new book and Netflix special

Tesla Inc.’s rough stretch in Europe continued as data from Germany and the U.K. showed the U.S.-based electric-vehicle maker’s sales were cut in half last month.

The stock market could soar even higher if these pillars of strength are unleashed, says Jim Paulsen of Paulsen Perspectives.

“A company representative said the account needed to be emptied within a 10-year period.”

Gundlach foresees a weaker dollar and a steeper yield curve

Post Content

Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy drugs used for weight loss, was downgraded due to competition from compounding as well as arch rival Eli Lilly, a brokerage said on Tuesday.

Sallie Mae says the average amount taken out in home-equity loans, retirement withdrawals and credit cards all jumped in 2025.

As more big restaurant chains prepare to report quarterly results this week, casual-dining chain Denny’s Corp.’s diagnosis of U.S. diners wasn’t great, as customers try to sniff out more discounts.

Shares of Hims & Hers Inc. fell after hours on Monday after the wellness and telehealth platform’s third-quarter forecast came up shy of Wall Street’s estimates, although the company stuck with its full-year outlook.

President Trump’s pick to run the federal agency that produces the critical U.S. jobs report might not be able to make it more reliable — and a new commissioner could even make the problems worse.